|
Market Cap (17-May) $539,831,168 (262nd) |
Close (30-Jun) $17.88 |
Volume (30-Jun) 66,664 |
Shortsold (5-May) 2,900,461 (5.79%) (38th) |
|
52w High $17.65 |
52w Low $9.76 |
P/E 14.22 |
EPS 0.77 |
CUV released this announcement to the ASX on 15 February 2023, 9:27. The announcement is not marked as price sensitive, and is 3 page(s) in length and 257.84kb in size.
You can view all announcements from CUV and see how they appear on a price chart on the announcements page.
At the date of this announcement, CUV was 5.957% short sold according to ASIC data. It was ranked the 17th most shorted stock on the ASX. It remains ranked 38th as of the latest reported data (05 May 2025).
| Other Recent Announcements from CUV | |
|---|---|
| Notification regarding unquoted securities - CUV | 30 June 2023, 11:51 |
| Two Grounds of Appeal Upheld by NICE Panel | 30 June 2023, 9:17 |
| Notification of cessation of securities - CUV | 29 June 2023, 11:44 |
| PRENUMBRA formulation completed for clinical trial use | 15 February 2023, 9:27 |
| Chair's Letter | 9 February 2023, 10:47 |
| Technical note - CUV151 results | 2 February 2023, 10:34 |
| Afamelanotide reduces UV skin damage in a healthy population | 2 February 2023, 10:34 |
You must be logged in to post a reply.
